First Trust Advisors LP increased its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 231.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 478,098 shares of the real estate investment trust’s stock after buying an additional 333,998 shares during the period. First Trust Advisors LP owned about 0.07% of Healthpeak Properties worth $9,691,000 at the end of the most recent quarter.
A number of other hedge funds also recently added to or reduced their stakes in DOC. Mizuho Bank Ltd. purchased a new stake in shares of Healthpeak Properties during the fourth quarter worth $28,000. Harvest Fund Management Co. Ltd purchased a new position in Healthpeak Properties in the fourth quarter valued at $30,000. Covestor Ltd increased its holdings in Healthpeak Properties by 173.8% in the fourth quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust’s stock valued at $37,000 after buying an additional 1,152 shares during the last quarter. AdvisorNet Financial Inc increased its holdings in Healthpeak Properties by 34.5% in the fourth quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock valued at $44,000 after buying an additional 563 shares during the last quarter. Finally, Kestra Investment Management LLC purchased a new position in Healthpeak Properties in the fourth quarter valued at $45,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at Healthpeak Properties
In related news, Director John T. Thomas bought 4,200 shares of the company’s stock in a transaction on Monday, April 28th. The stock was bought at an average cost of $17.84 per share, with a total value of $74,928.00. Following the completion of the acquisition, the director now owns 813,566 shares in the company, valued at approximately $14,514,017.44. This represents a 0.52 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Scott M. Brinker bought 11,337 shares of the company’s stock in a transaction on Monday, April 28th. The stock was bought at an average cost of $17.68 per share, with a total value of $200,438.16. Following the completion of the acquisition, the chief executive officer now owns 201,863 shares of the company’s stock, valued at $3,568,937.84. This represents a 5.95 % increase in their position. The disclosure for this purchase can be found here. 0.23% of the stock is owned by insiders.
Healthpeak Properties Price Performance
Healthpeak Properties (NYSE:DOC – Get Free Report) last announced its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The business had revenue of $702.89 million during the quarter, compared to the consensus estimate of $690.76 million. During the same quarter in the prior year, the firm earned $0.45 earnings per share. The business’s quarterly revenue was up 15.9% compared to the same quarter last year. On average, equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.
Healthpeak Properties Announces Dividend
The company also recently disclosed a dividend, which will be paid on Wednesday, April 30th. Investors of record on Friday, April 18th will be given a $0.1017 dividend. The ex-dividend date of this dividend is Thursday, April 17th. This represents a yield of 6.5%. Healthpeak Properties’s payout ratio is currently 305.00%.
Analyst Ratings Changes
Several research firms recently commented on DOC. Evercore ISI dropped their target price on Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating on the stock in a report on Monday. Scotiabank dropped their target price on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a report on Friday, February 28th. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price on the stock in a report on Wednesday, January 15th. Wedbush dropped their target price on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a report on Monday. Finally, Robert W. Baird decreased their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Tuesday, February 11th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Healthpeak Properties has a consensus rating of “Moderate Buy” and an average price target of $23.45.
View Our Latest Stock Analysis on DOC
Healthpeak Properties Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Recommended Stories
- Five stocks we like better than Healthpeak Properties
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Best Defense Stocks in 2025… So Far
- What is a Microcap Stock? Everything You Need to Know
- Alphabet Rebounds After Strong Earnings and Buyback Announcement
- What is the MACD Indicator and How to Use it in Your Trading
- Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret?
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC – Free Report).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.